Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Jun 2027. The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify s…
Opportunity overview
- Project name
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)?
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Jun 2027. The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify s…
Who is funding Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)?
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)?
The application deadline is 02 Jun 2027 00:00 (UTC).
Where will the Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.